GleamWall
中文EN

VNOV VitaNova Life Sciences Corp

Wholesale-Apparel, Piece Goods & Notions · OTC · SEC CIK 1699709 · Fiscal year ends 04/30

Financial factors as of 2026-07-31 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY22.0%
TTM net income YoY-113.3%
TTM EPS YoY—
Revenue 3-yr CAGR420.5%
Net income 3-yr CAGR—

Margins

Gross margin26.9%
Operating margin-2.7%
Net margin-3.5%
FCF margin—
EBITDA margin—

Returns

ROE-6.0%
ROA-5.1%
ROIC (approx.)-11.9%
Asset turnover1.45x

Leverage & solvency

Liabilities / assets13.9%
Debt / equity0.00x
Current ratio7.13x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-4.89x
Accruals ratio-30.0%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2027Q12026-07-312026Q4*2026-04-302026Q32026-01-312026Q22025-10-312026Q12025-07-312025Q4*2025-04-302025Q32025-01-312025Q22024-10-31
Income statement
Revenue$321,576$1.78M$709,625$427,115$103,899$1.95M$308,318$292,118
Cost of revenue$291,055$1.52M$393,282$166,312$35,118$795,801$119,006$136,284
Gross profit$30,521$264,662$316,343$260,803$68,781$1.16M$189,312$155,834
SG&A expense$114,831$328,457$219,600$119,444$66,293$29,775$30,667$40,107
Operating income-$122,162-$109,860$46,731$99,170-$32,440$1.08M$108,874$62,600
Interest expense—$0$0$0—$1,568$813$2,125
Pretax income—-$107,000$46,731$99,290-$32,440$1.08M$108,257$60,775
Income tax$939-$124,549$91,093$63,480$13,861$280,354$35,279$28,128
Net income-$123,101$17,549-$44,362$35,810-$46,301$800,332$72,978$32,647
EPS (basic)-0.01—-0.010.00-0.01—0.010.00
EPS (diluted)——-0.010.000.00—0.010.00
Weighted avg. shares (diluted)——8.34M25.01M25.01M—8.34M25.01M
Balance sheet
Cash & equivalents$1.60M$1.60M$1.17M$1.26M$1.05M$782,810$405,173$222,795
Receivables$316,871$726,743$1.00M$882,612$1.01M$1.27M$54,018$57,700
Inventory$301,294$105,613$130,436$11,267$9,130$44,247$186,727$303,094
Current assets$2.22M$2.43M$2.31M$2.34M$2.24M$2.26M$1.32M$1.26M
Total assets$2.24M$2.45M$2.31M$2.34M$2.24M$2.26M$1.32M$1.26M
Current liabilities$311,656$395,781$457,975$438,051$379,975$347,567$212,789$223,938
Total liabilities$311,656$395,781$457,975$438,051$379,975$347,567$212,789$223,938
Shareholders' equity$1.93M$2.05M$1.85M$1.90M$1.86M$1.91M$1.11M$1.03M
Shares outstanding8.34M8.34M—25.01M25.01M8.34M25.01M25.01M
Cash flow statement
Operating cash flow$6,965$428,313-$90,377$212,661$263,811$479,137$208,878$8,760
Financing cash flow—$0$0$0$0-$101,500-$26,500$72,400
Stock-based compensation—$179,400$0$0$0$0$500$750

Free plan shows the latest 8 periods; Pro shows all 38 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.